Literature DB >> 20925565

Implementation of a wireless device for real-time telemedical assistance of home-ventilated amyotrophic lateral sclerosis patients: a feasibility study.

Jos Pedro Lopes de Almeida1, Anabela C Pinto, Joo Pereira, Susana Pinto, Mamede de Carvalho.   

Abstract

Neuromuscular disorders encompass a wide category of illnesses with a significant burden on the patient, family, and society. Telehome monitoring presents an alternative for closer follow-up, by ensuring timely transmission of data and prompting medical support before deterioration occurs. We used telehome monitoring devices for amyotrophic lateral sclerosis patients with respiratory failure in a clinic. This instrument directly acts as a digital recorder of parameters received from an external instrument, such as the bi-level ventilator, and contains an internal modem for direct connection to the Internet, thereby allowing bidirectional flexibility in collecting data and parameter changes whenever needed. The use and acceptance of the system was investigated with patients and all therapists involved. The instrument was found to be user-friendly and effective by the researchers, being practical for both patients and therapists. Therefore, it can be integrated into a routine home care application based on a large respiratory rehabilitation center. The device was extensively tested, and in an ongoing randomized controlled study it is being investigated whether this management strategy is able to hasten the ventilator adaptation process and to diminish the overall utilization of health services, with concurrent economic viability. We conclude that home telemonitoring represents a positive contribution to the management of chronic patients and raised awareness of it should be considered in a near future. This portable telemonitoring device provides an opportune approach to better understand and recognize a ventilatory pattern through long-term ventilation monitoring in the home environment.

Entities:  

Mesh:

Year:  2010        PMID: 20925565     DOI: 10.1089/tmj.2010.0042

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  7 in total

Review 1.  Telepsychiatry in the 21(st) century: transforming healthcare with technology.

Authors:  Stacie Deslich; Bruce Stec; Shane Tomblin; Alberto Coustasse
Journal:  Perspect Health Inf Manag       Date:  2013-07-01

2.  Assessment of the feasibility of an ultra-low power, wireless digital patch for the continuous ambulatory monitoring of vital signs.

Authors:  Miguel Hernandez-Silveira; Kamran Ahmed; Su-Shin Ang; Fahriya Zandari; Tinaz Mehta; Rebecca Weir; Alison Burdett; Chris Toumazou; Stephen J Brett
Journal:  BMJ Open       Date:  2015-05-19       Impact factor: 2.692

Review 3.  New technologies and Amyotrophic Lateral Sclerosis - Which step forward rushed by the COVID-19 pandemic?

Authors:  Susana Pinto; Stefano Quintarelli; Vincenzo Silani
Journal:  J Neurol Sci       Date:  2020-08-05       Impact factor: 3.181

4.  The Transitions to Long-term In Home Ventilator Engagement Study (Transitions to LIVE): study protocol for a pragmatic randomized controlled trial.

Authors:  Reshma Amin; Andrea Gershon; Louise Rose; Francine Buchanan; Regina Pizzuti; Adam Qazi; Nishali Patel; Ruxandra Pinto; Myla E Moretti; Munazzah Ambreen
Journal:  Trials       Date:  2022-02-07       Impact factor: 2.279

Review 5.  How to manage with telemedicine people with neuromuscular diseases?

Authors:  Fiore Manganelli; Luigi Lavorgna; Emanuele Spina; Francesca Trojsi; Stefano Tozza; Aniello Iovino; Rosa Iodice; Carla Passaniti; Gianmarco Abbadessa; Simona Bonavita; Letizia Leocani; Gioacchino Tedeschi
Journal:  Neurol Sci       Date:  2021-06-25       Impact factor: 3.307

Review 6.  Telemedicine in the management of patients with chronic respiratory failure.

Authors:  Neeraj M Shah; Georgios Kaltsakas
Journal:  Breathe (Sheff)       Date:  2021-03

7. 

Authors:  Reshma Amin; Regina Pizzuti; Francine Buchanan; Louise Rose
Journal:  CMAJ       Date:  2021-07-12       Impact factor: 8.262

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.